SRZN: Surrozen, Inc.
Performance
SRZN +162.30%
Watchlist
Select an item
Summary
SRZN at a glance
SRZN returned +162.30% over the past year and -22.12% a year over five years. Its worst drop in that year was -52.65%, smaller than 19% of stocks on Redstone, and its Sharpe ratio of 1.19 beats 83% of stocks on Redstone. It pays no dividends.
Current Drawdown
-6.24%
Rolling Volatility
92.37%
Actions
Metrics
Risk Indicators
Alpha146.38%
Beta1.53x
Sharpe1.19
Sortino3.00
Omega1.36
Calmar3.08
Martin7.10
Profile
About SRZN
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $376M
- Listed
- Aug 2021
- Employees
- 44
- Headquarters
- South San Francisco, CA
- Website
- surrozen.com
Comparisons